Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3958445
Max Phase: Preclinical
Molecular Formula: C17H16O5S2
Molecular Weight: 364.44
Molecule Type: Small molecule
Associated Items:
ID: ALA3958445
Max Phase: Preclinical
Molecular Formula: C17H16O5S2
Molecular Weight: 364.44
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=S1(=O)C=C(c2ccc(Oc3ccccc3)cc2)S(=O)(=O)CCC1
Standard InChI: InChI=1S/C17H16O5S2/c18-23(19)11-4-12-24(20,21)17(13-23)14-7-9-16(10-8-14)22-15-5-2-1-3-6-15/h1-3,5-10,13H,4,11-12H2
Standard InChI Key: SMZPMKLLNJSJSF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 364.44 | Molecular Weight (Monoisotopic): 364.0439 | AlogP: 3.01 | #Rotatable Bonds: 3 |
Polar Surface Area: 77.51 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 1.12 | CX LogD: 1.12 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.84 | Np Likeness Score: -0.44 |
1. (2002) 1,4-dithiin and 1,4-dithiepin-1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor, |
Source(1):